ArticleHaematologica2020

Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models.

Lina Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.